Researchers conducted a randomised, open-label, factorial phase 3 trial including 261 patients with resectable or borderline resectable PDAC across 17 Italian academic hospitals. Patients were ...
CHICAGO -- A neoadjuvant chemotherapy regimen of cisplatin (Platinol), nab-paclitaxel (Abraxane), capecitabine (Xeloda), and gemcitabine (PAXG) topped a standard option in a randomized trial of ...
PAXG spiked as high as $2,923 on Saturday, trading at premium of over 20% to gold's per ounce price of $2,342.90 on Friday. Bitcoin traded at a perfect negative correlation to PAXG in a sign of weak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results